By LUKE OAKDEN-RAYNER I’ve been talking in recent posts about how our typical methods of testing AI systems are inadequate and potentially unsafe. In particular, I’ve complainedthat all of the headline-grabbing papers so far only do controlled experiments, so we don’t how the AI systems will perform on real patients. Today I am going to highlight… Read More »
The global search for a group A streptococcal (Strep A) vaccine has narrowed after researchers identified a common gene signature in almost all global Strep A strains by sequencing thousands of genomes in a project spanning 10 years and more than 20 countries. Strep A, is a bacterial pathogen that in some regions of the… Read More »
I’ve written about the collusion between industry and the U.S. federal regulatory agencies on many occasions throughout the years, and how industry-funded research simply tends to promote and support the industry agenda rather than shed truthful light on the benefits or risks of any given product. In recent years, the hidden influence of The Coca-Cola… Read More »
Scientists have identified an enzyme that is a “master regulator” of kidney function that if excessively suppressed, can trigger renal failure. Their findings have implications for the use of existing drugs and the development of new pharmaceuticals. As reported in Nature Communications, a global research team led by the University of Bristol studied how the activity… Read More »